TF and glioblastoma: CRT-NP exhibited higher levels of penetration and accumulation at the tumour site compared to Coumarin-6-labelled NPs and Tf-NPs alone (2.41-fold and 1.43-fold change, respectively) [52], highlighting the potential of CRT peptide as a targeting ligand for enhanced drug delivery in GBM.